Cannabis Science, Inc. (CBIS) Enters Transition Stage as Trading of the Company’s Shares is Halted
Marijuana Industry NewsUncategorized September 6, 2019
Cannabis Science Enters Transition Stage as Trading of the Company’s Shares is…
The post Cannabis Science, Inc. (CBIS) Enters Transition Stage as Trading of the Company’s Shares is Halted appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Read more
Mr. Raymond C. Dabney Prepares Cannabis Science, Inc. (CBIS) for the Next Level
Marijuana Industry NewsUncategorized July 8, 2019
Mr. Raymond C. Dabney Prepares Cannabis Science for the Next Level With Key Acquisitions Negotiated and Planned Mergers, a New Branding Splash, and a Black-Tie Dinner Awards Gala for the Ages Cannabis Science, Inc. (CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that Mr. Raymond C. Dabney (RCD), […]
The post Mr. Raymond C. Dabney Prepares Cannabis Science, Inc. (CBIS) for the Next Level appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Read more
Cannabis Science, Inc. (CBIS) Set to Participate in the Premier Event Focused on High-Impact Global Collaborations
Marijuana Industry NewsUncategorized May 25, 2019
Cannabis Science Set to Participate in the Premier Event Focused on High-Impact Global Collaborations; The Global Health Catalyst Summit at Harvard Medical School Starts Today Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the Company’s participation in the 2019 Global Health Catalyst (GHC) Summit at […]
The post Cannabis Science, Inc. (CBIS) Set to Participate in the Premier Event Focused on High-Impact Global Collaborations appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Read more
Cannabis Science, Inc. (CBIS) Releases Clinical Drug-Development Pipeline
Marijuana Industry NewsUncategorized May 11, 2019
Cannabis Science Releases Clinical Drug-Development Pipeline as it Transitions Into Clinical Trials; Right on Time for the Upcoming Global Health Catalyst Summit at Harvard Medical School, May 24-26, 2019 Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, hits inflection point that translates into an unprecedented progression to clinical trials. […]
The post Cannabis Science, Inc. (CBIS) Releases Clinical Drug-Development Pipeline appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Read more
Cannabis Science, Inc. (CBIS) Receives Tremendous Response for CEO’s Personal Shareholder Loyalty Gift
Marijuana Industry NewsUncategorized February 9, 2019
Cannabis Science Receives Tremendous Response for CEO’s Personal Shareholder Loyalty Gift; Planning Underway for the Company’s 2019 Black-Tie Dinner Awards Gala Presentations Cannabis Science, Inc. (CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces that it has received an incredible response from shareholders registering for RCD Personal Shareholder Loyalty Gift. Mr. Raymond […]
The post Cannabis Science, Inc. (CBIS) Receives Tremendous Response for CEO’s Personal Shareholder Loyalty Gift appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Read more
